Literature DB >> 19492035

Ventricular pacing thresholds following high-energy implantable cardioverter defibrillator shocks in integrated bipolar defibrillation systems.

Yoshio Yamanouchi1, Kei Miyoshi, Sunao Kodama, Yuhei Shiga, Shunichiro Sumi, Hideya Niimura, Hideaki Toujou, Hidenori Urata.   

Abstract

BACKGROUND: Increased ventricular pacing thresholds have been observed following monophasic implantable cardioverter defibrillator (ICD) shocks. AIM: To examine changes following high-energy biphasic shocks delivered by integrated bipolar ICD systems.
METHOD: Ten episodes of ventricular fibrillation (VF) were induced at 10 min intervals in nine pigs with integrated ICD systems. After 10 s of each episode of VF, a 40 J biphasic shock was delivered, which successfully terminated VF (a total of 10 shocks). The bipolar pacing threshold at the right ventricular apex was measured before each shock and at 1 min intervals after each shock.
RESULTS: The mean pacing threshold was 0.029+/-0.059 muJ before the first shock and gradually increased to 0.14+/-0.10 muJ after the 10th shock.
CONCLUSION: It may be necessary to pace at a high-voltage output following biphasic shocks delivered by integrated bipolar ICD systems.

Entities:  

Keywords:  High-energy ICD shock; Pacing threshold

Year:  2009        PMID: 19492035      PMCID: PMC2689086     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  12 in total

1.  Fully discharging phases. A new approach to biphasic waveforms for external defibrillation.

Authors:  Y Yamanouchi; J E Brewer; K F Olson; K A Mowrey; T N Mazgalev; B L Wilkoff; P J Tchou
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

2.  Defibrillation shocks increase myocardial pacing threshold: an intracellular microelectrode study.

Authors:  H G Li; D L Jones; R Yee; G J Klein
Journal:  Am J Physiol       Date:  1991-06

3.  Optimal small-capacitor biphasic waveform for external defibrillation: influence of phase-1 tilt and phase-2 voltage.

Authors:  Y Yamanouchi; J E Brewer; K A Mowrey; A M Donohoo; B L Wilkoff; P J Tchou
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

4.  Effects of ventricular fibrillation and defibrillation on pacing threshold in the anesthetized dog.

Authors:  M J Reiter; J Lindenfeld; C M Tyndal; S Breckinridge; D E Mann
Journal:  J Am Coll Cardiol       Date:  1989-01       Impact factor: 24.094

5.  Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds.

Authors:  P J Kudenchuk; J E Poole; G L Dolack; M J Gleva; J Anderson; C Troutman; G H Bardy
Journal:  J Cardiovasc Electrophysiol       Date:  1997-05

6.  Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: comparison with a standard monophasic device using the same lead system.

Authors:  A Natale; J Sra; K Axtell; C Maglio; A Dhala; S Deshpande; M Jazayeri; A Wase; M Akhtar
Journal:  J Am Coll Cardiol       Date:  1994-08       Impact factor: 24.094

7.  Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems.

Authors:  P A Levine; S S Barold; R D Fletcher; P Talbot
Journal:  J Am Coll Cardiol       Date:  1983-06       Impact factor: 24.094

8.  Ventricular pacing threshold and refractoriness after defibrillation shocks in patients with implantable cardioverter-defibrillators.

Authors:  J C Yu; M R Lauer; C Young; B Liem; J Peterson; L Ottoboni; R J Sung
Journal:  Am Heart J       Date:  1996-06       Impact factor: 4.749

9.  Optimization of biphasic waveforms for human nonthoracotomy defibrillation.

Authors:  J F Swartz; R D Fletcher; P E Karasik
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

10.  Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients.

Authors:  G Altamura; L Bianconi; F Lo Bianco; S Toscano; F Ammirati; C Pandozi; A Castro; M Cardinale; M Mennuni; M Santini
Journal:  Pacing Clin Electrophysiol       Date:  1995-01       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.